Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
02/26/2002 | US6350855 Human interleukin-11 receptor |
02/26/2002 | US6350854 Isolated 55 to 72 kDa protein which binds to prion proteins |
02/26/2002 | US6350853 Conjugated peptide nucleic acids having enhanced cellular uptake |
02/26/2002 | US6350767 Growth hormone release stimulant |
02/26/2002 | US6350731 Platelet-derived growth factor analogues |
02/26/2002 | US6350730 OB polypeptides and modified forms as modulators of body weight |
02/26/2002 | US6350615 Screening compound for ability to modulate k12 protein growth promoting activity by incubating k12 protein, or portion thereof, with susceptible cells in presence and absence of compound, assaying for alteration in growth rate |
02/26/2002 | US6350612 Cloned and sequenced eco ri fragment of bordetella pertussis chromosomal dna with 4696 base pairs containing genes which code for five subunits of pertussis toxin or fragments thereof containing at least one gene which codes for subunit of toxin |
02/26/2002 | US6350593 Receptors for fibroblast growth factors |
02/26/2002 | US6350592 Aortic-specific enhancer sequence and uses thereof |
02/26/2002 | US6350590 Tolerogenic fragments of natural allergens |
02/26/2002 | US6350589 Compositions of highly-purified natural mixtures of type I interferon derived from leukocytes and methods |
02/26/2002 | US6350587 Bacillus strain and antibiotic screening method |
02/26/2002 | US6350581 Tumor-associated antigen |
02/26/2002 | US6350572 Interaction between cyclin D1 and steroid receptor coactivators and users thereof in assays |
02/26/2002 | US6350456 Composition comprising purified first and second polypeptides and physiologically acceptable carrier, wherein each polypeptide comprises immunogenic portion of mycobacterium tuberculosis antigen having specified amino acid sequence |
02/26/2002 | US6350450 Isolated antibody which specifically binds to mammalian nl1 tie ligand polypeptide which has specified amino acid sequence and is capable of inducing vascularization |
02/26/2002 | US6350447 Polypeptides with amino acid sequences and proteins |
02/26/2002 | US6350443 Method of treatment for feline leukemia virus infections |
02/26/2002 | US6350430 Melanocortin receptor ligands and methods of using same |
02/26/2002 | CA2083177C Alveolar surfactant proteins |
02/26/2002 | CA2078875C High level expression of basic fibroblast growth factor having a homogeneous n-terminus |
02/26/2002 | CA2038030C Synthetic peptides which contain sequences from factor viia, and the use thereof |
02/26/2002 | CA1341343C Immunoassay and biological constructs for use therein |
02/25/2002 | CA2315900A1 Apple mads-box protein, gene encoding said protein, antibody against said protein, method for detecting transcript of said gene or protein expressed therefrom and process for preparing transgenic plant containing said gene |
02/21/2002 | WO2002014870A2 Use of antibodies against specific mhc-peptide complexes |
02/21/2002 | WO2002014532A2 Method for identifying modulators of 'mec'-induced functions of ccr3 and/or ccr10 |
02/21/2002 | WO2002014526A2 Replication competent aav helper functions |
02/21/2002 | WO2002014525A2 Expression vector using for animal cell |
02/21/2002 | WO2002014519A1 A method to increase cerebral blood flow in amyloid angiopathy |
02/21/2002 | WO2002014518A1 Method of modifying microorganism-origin transglutaminase |
02/21/2002 | WO2002014517A1 BROAD-SPECTRUM δ-ENDOTOXINS |
02/21/2002 | WO2002014516A1 Novel diagnostic agents of chronic or persistent chlamydial diseases and uses thereof |
02/21/2002 | WO2002014515A1 Nucleic acids and proteins showing increased expression dose under salt stress |
02/21/2002 | WO2002014514A1 A fibrinogen clotting inhibitor derived from snake venom and process for preparing the same |
02/21/2002 | WO2002014513A1 Use of polypeptide |
02/21/2002 | WO2002014511A2 Regulation of human p2y1-like g protein-coupled receptor |
02/21/2002 | WO2002014510A1 A novel polypeptide- human cbp20 protein 47.74 and the polynucleotide encoding said polypeptide |
02/21/2002 | WO2002014505A1 Collagen-binding hybrid polypeptide |
02/21/2002 | WO2002014504A1 Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin d metabolism and dnas encoding the same |
02/21/2002 | WO2002014503A2 Compositions and methods for the therapy and diagnosis of her-2/neu-associated malignancies |
02/21/2002 | WO2002014502A2 Sclerotinia-inducible genes and promoters and their uses |
02/21/2002 | WO2002014501A2 Nucleic acids and corresponding proteins entitled phor1-a11 and phor1-f5d6 useful in treatment and detection of cancer |
02/21/2002 | WO2002014500A2 Human genes and gene expression products |
02/21/2002 | WO2002014499A2 Claudin polypeptides |
02/21/2002 | WO2002014498A2 Human voltage-gated sodium channel proteins (scn1a) and polynucleotides encoding the same |
02/21/2002 | WO2002014496A2 G protein-coupled receptors |
02/21/2002 | WO2002014492A2 Fatty liver disease resistant bovines |
02/21/2002 | WO2002014491A2 A hematopoietic growth factor-like protein obtained from a cdnalibrary from hs-5 stromal cell line |
02/21/2002 | WO2002014489A2 Leucine-rich repeat-containing g-protein coupled receptor-8 molecules and uses thereof |
02/21/2002 | WO2002014488A1 Novel protein derived from agkistrodon saxatilis emelianov and process for preparing the same |
02/21/2002 | WO2002014487A2 Adeno-associated virus-mediated delivery of angiogenic factors |
02/21/2002 | WO2002014478A2 IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY |
02/21/2002 | WO2002014474A2 Method of treating alzheimer's disease with cell therapy |
02/21/2002 | WO2002014473A2 Animals expressing exogenous igf-i in their milk |
02/21/2002 | WO2002014471A2 A method of producing biologically active human acidic fibroblast growth factor and its use in promoting angiogenesis |
02/21/2002 | WO2002014470A2 Expression of herstatin, an alternative her-2/neu product, in cells that express either p185her-2 or the egf receptor inhibits receptor activity and cell growth |
02/21/2002 | WO2002014468A2 Phage-dependent superproduction of biologically active protein and peptides |
02/21/2002 | WO2002014467A2 Cng2b: a putative human cyclic nucleotide-gated ion channel |
02/21/2002 | WO2002014373A1 Protein monitoring the activity of low-molecular weight gtp-binding protein |
02/21/2002 | WO2002014372A1 Activity monitor protein for low-molecular weight gtp-binding protein |
02/21/2002 | WO2002014370A1 Hepatitis b virus (hbv) antigenic polypeptide-heat shock protein complex and use thereof |
02/21/2002 | WO2002014369A2 Human kininogen d5 domain polypeptides and their use |
02/21/2002 | WO2002014368A2 Proteins and nucleic acids encoding the same |
02/21/2002 | WO2002014367A1 Chimeric human-type vascular endothelial cell growth factor |
02/21/2002 | WO2002014366A2 Genes involved in immune related responses observed with asthma |
02/21/2002 | WO2002014365A1 A new polypeptide-ras gtp activator protein 12 and the polynucleotide encoding it |
02/21/2002 | WO2002014364A2 Rattlesnake venom gland proteins |
02/21/2002 | WO2002014363A2 Influencing the distribution of metals in transgenic plants |
02/21/2002 | WO2002014362A2 A hepatitis c virus non-structural ns3/4a fusion gene |
02/21/2002 | WO2002014361A2 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 83P2H3 AND CaTrF2E11 USEFUL IN TREATMENT AND DETECTION OF CANCER |
02/21/2002 | WO2002014360A1 Integrin binding motif containing peptides and methods of treating skeletal diseases |
02/21/2002 | WO2002014359A2 Human serpin zserp15 |
02/21/2002 | WO2002014358A2 Novel secreted proteins and their uses |
02/21/2002 | WO2002014357A2 Use of gadd34 or pcna polypeptides in the treatment of cerebral ischaemic damage |
02/21/2002 | WO2002014356A2 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects |
02/21/2002 | WO2002014352A2 Therapeutic compounds for ovarian cancer |
02/21/2002 | WO2002014351A2 α7 NICOTINIC RECEPTOR PEPTIDES AS LIGANDS FOR β AMYLOID P EPTIDES |
02/21/2002 | WO2002014350A2 Peptide and peptide mimetic derivatives with integrin inhibitor properties ii |
02/21/2002 | WO2002014348A2 Glycoproteins and methods of use thereof |
02/21/2002 | WO2002014347A2 Method for producing peptide salts, their use, and pharmaceutical preparations containing these peptide salts |
02/21/2002 | WO2002014346A2 Antimicrobial peptides isolated from fish |
02/21/2002 | WO2002014345A2 Antimicrobial peptides isolated from mast cells |
02/21/2002 | WO2002014341A1 8 human secreted proteins |
02/21/2002 | WO2002013855A2 Vaccines containing ribavirin and methods of use thereof |
02/21/2002 | WO2002013848A1 Highly homogeneous molecular markers for electrophoresis |
02/21/2002 | WO2002013845A2 Inflammation related g-protein coupled receptor |
02/21/2002 | WO2002013837A1 A novel animal model of alzheimer's disease using genetically altered stem cells |
02/21/2002 | WO2002013775A1 Dental products comprising bone growth enhancing peptide |
02/21/2002 | WO2002013765A2 Malaria immunogen and vaccine |
02/21/2002 | WO2002013763A2 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
02/21/2002 | WO2002013609A1 METHODS FOR BLOCKING RESISTANCE TO Bt TOXINS IN INSECTS AND NEMATODES |
02/21/2002 | WO2002013606A2 Improved insecticidal bacteria, and methods for making and using them |
02/21/2002 | WO2001094530A3 A novel polypeptide, a scan zinc-finger protein subfamily protein 57 and the polynucleotide encoding the polypeptide |
02/21/2002 | WO2001082943A3 Subcutaneous administration of coagulation factor vii |
02/21/2002 | WO2001080639A3 Hr-elicitors to inhibit postharvest disease or desiccation of fruits or vegetables |
02/21/2002 | WO2001079443A3 Albumin fusion proteins |
02/21/2002 | WO2001079435A3 A new polypeptide- human flavoprotein subunit 14 and the polynucleotide encoding it |
02/21/2002 | WO2001077329A8 Human twik molecules and uses thereof |
02/21/2002 | WO2001077149A3 Regulation of human cyslt2-like gpcr protein |